The efficacy of CP7_E2alf: an animal study involving piglets from C–strain vaccinated sows by Rangelova, Desislava Yordanova et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 20, 2017
The efficacy of CP7_E2alf: an animal study involving piglets from C–strain vaccinated
sows
Rangelova, Desislava Yordanova; Nielsen, Jens; Strandbygaard, Bertel; Blome, Sandra; Uttenthal, Åse
Publication date:
2012
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Rangelova, D. Y., Nielsen, J., Strandbygaard, B., Blome, S., & Uttenthal, Å. (2012). The efficacy of CP7_E2alf:
an animal study involving piglets from C–strain vaccinated sows. Abstract from Annual Meeting of the National
Reference Laboratories of CSF, Hannover, Germany.
The efficacy of CP7_E2alf: an animal study involving piglets from C–strain 
vaccinated sows 
Desislava Rangelovaa, Jens Nielsen
a
, Bertel Strandbygaard
a
, Sandra Blome
b
, Åse Uttenthal
a 
a
Technical University of Denmark, National Veterinary Institute, Lindholm, DK-4771Kalvehave, Denmark 
b
Friedrich-Loeffler-Institute, Institute of Diagnostic Virology, Suedufer 10, 17493 Greifswald-Insel Riems, 
Germany 
 
Outbreaks of Classical Swine Fever (CSF) in the European Union have caused enormous 
economical losses. To facilitate the possibility of free trade with pigs and their products, a chimeric 
live DIVA vaccine CP7_E2alf was developed. Most likely, passive immunity against CSF virus in 
populations previously vaccinated with C-strain interferes with the efficacy of CP7_E2alf 
vaccination. To study the interaction with maternal antibodies, the efficacy of CP7_E2alf in piglets 
from C-strain vaccinated sows was examined. At 5 or at 8 weeks of age, piglets were vaccinated 
with CP7_E2alf. The vaccinated piglets together with mock-vaccinated littermate controls were 
challenged 2 weeks post vaccination with highly virulent CSFV Kozlov. The results showed that 
CP7_E2alf is effective in preventing mortality, severe clinical signs and pathological lesions in 
piglets vaccinated at 5 or at 8 weeks of age. Interestingly, the antibodies in the mock-vaccinated 
control piglets partly neutralized the challenge virus. In earlier studies CSFV Koslov has resulted in 
100% mortality in naïve piglets, in this study mortality was reduced to 30% in the piglets infected at 
7 weeks of age and to 50% in the piglets infected at 10 weeks of age. In the present study optimal 
time point for vaccination of piglets with passive immunity was found to be 5 weeks of age. 
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